|
ZNF845 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30910005058382E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08030000500747E-08 |
| Normal-vs-Stage2 |
1.51309999973925E-07 |
| Normal-vs-Stage3 |
1.12720000000621E-09 |
| Normal-vs-Stage4 |
1.09060538378003E-11 |
| Stage1-vs-Stage2 |
6.206600E-01 |
| Stage1-vs-Stage3 |
1.884820E-01 |
| Stage1-vs-Stage4 |
2.124700E-03 |
| Stage2-vs-Stage3 |
6.629400E-01 |
| Stage2-vs-Stage4 |
8.696100E-02 |
| Stage3-vs-Stage4 |
1.031380E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.80209999647951E-09 |
| Normal-vs-AfricanAmerican |
8.43520000515241E-08 |
| Normal-vs-Asian |
2.14469999981759E-07 |
| Caucasian-vs-AfricanAmerican |
5.954800E-01 |
| Caucasian-vs-Asian |
8.913800E-01 |
| AfricanAmerican-vs-Asian |
5.603400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00499997213177E-09 |
| Normal-vs-Female |
2.3695999606943E-09 |
| Male-vs-Female |
4.755000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.96359999873985E-08 |
| Normal-vs-Age(41-60Yrs) |
6.30140051249839E-10 |
| Normal-vs-Age(61-80Yrs) |
1.19870002812661E-09 |
| Normal-vs-Age(81-100Yrs) |
3.443500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.381440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.590840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.553800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.250400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.830400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.523600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.208820E-01 |
| Classical-VS-Follicular |
1.928100E-02 |
| Classical-VS-Other |
1.568580E-01 |
| Classical-VS-Normal |
3.77050000111012E-08 |
| Tall-VS-Follicular |
9.991400E-01 |
| Tall-VS-Other |
5.409400E-01 |
| Tall-VS-Normal |
1.75019999604231E-08 |
| Follicular-VS-Other |
5.785000E-01 |
| Follicular-VS-Normal |
7.30079996458244E-10 |
| Other-VS-Normal |
1.375890E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28029994886469E-09 |
| Normal-vs-N1 |
3.11579984035859E-10 |
| N0-vs-N1 |
1.172970E-01 |
|
|
